Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meenakshi Bewtra

Showing results (1-10 of 77) with videos related to

Pageof 8
Sort By:
The American Journal of Gastroenterology|July 6, 2012
Lymphoma in inflammatory bowel disease and treatment decisionsMeenakshi Bewtra
Inflammatory Bowel Diseases|December 6, 2014
An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo Score and the Simple Clinical Colitis Activity IndexMeenakshi Bewtra
Academic Medicine : Journal of the Association of American Medical Colleges|September 14, 2002
Gold Foundation essay. The clinical experience that taught me the mostMeenakshi Bewtra
Gastroenterology Clinics of North America|November 17, 2009
Safety profile of IBD: lymphoma risksMeenakshi Bewtra, James D Lewis
The American Journal of Gastroenterology|March 21, 2020
Mongersen and SMAD-7 Inhibition, Not a Lucky 7 for Patients With IBD: When Trial Design Is as Important as Disease TherapyMeenakshi Bewtra, Gary R Lichtenstein
Expert Review of Clinical Immunology|July 3, 2010
Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel diseaseMeenakshi Bewtra, James D Lewis
Digestive Diseases and Sciences|April 29, 2009
Secular trends in hospitalization for IBD: the ecological nicheMeenakshi Bewtra, James D Lewis
Expert Opinion on Biological Therapy|June 7, 2005
Infliximab use in Crohn's diseaseMeenakshi Bewtra, Gary R Lichtenstein
The Patient|October 16, 2013
Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative dataMeenakshi Bewtra, F Reed Johnson
The Medical Clinics of North America|December 1, 2009
Safety profile of IBD: lymphoma risksMeenakshi Bewtra, James D Lewis
Pageof 8

Showing results (1-10 of 77) with videos related to

Sort By:
Pageof 8
The American Journal of Gastroenterology|July 6, 2012
Lymphoma in inflammatory bowel disease and treatment decisionsMeenakshi Bewtra
Inflammatory Bowel Diseases|December 6, 2014
An optimized patient-reported ulcerative colitis disease activity measure derived from the Mayo Score and the Simple Clinical Colitis Activity IndexMeenakshi Bewtra
Academic Medicine : Journal of the Association of American Medical Colleges|September 14, 2002
Gold Foundation essay. The clinical experience that taught me the mostMeenakshi Bewtra
Gastroenterology Clinics of North America|November 17, 2009
Safety profile of IBD: lymphoma risksMeenakshi Bewtra, James D Lewis
The American Journal of Gastroenterology|March 21, 2020
Mongersen and SMAD-7 Inhibition, Not a Lucky 7 for Patients With IBD: When Trial Design Is as Important as Disease TherapyMeenakshi Bewtra, Gary R Lichtenstein
Expert Review of Clinical Immunology|July 3, 2010
Update on the risk of lymphoma following immunosuppressive therapy for inflammatory bowel diseaseMeenakshi Bewtra, James D Lewis
Digestive Diseases and Sciences|April 29, 2009
Secular trends in hospitalization for IBD: the ecological nicheMeenakshi Bewtra, James D Lewis
Expert Opinion on Biological Therapy|June 7, 2005
Infliximab use in Crohn's diseaseMeenakshi Bewtra, Gary R Lichtenstein
The Patient|October 16, 2013
Assessing patient preferences for treatment options and process of care in inflammatory bowel disease: a critical review of quantitative dataMeenakshi Bewtra, F Reed Johnson
The Medical Clinics of North America|December 1, 2009
Safety profile of IBD: lymphoma risksMeenakshi Bewtra, James D Lewis
Pageof 8